On Tuesday, Anavex Life Sciences Corporation (NASDAQ: AVXL) opened lower -8.76% from the last session, before settling in for the closing price of $8.33. Price fluctuations for AVXL have ranged from $3.25 to $14.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -22.44% at the time writing. With a float of $82.26 million, this company’s outstanding shares have now reached $84.99 million.
The firm has a total of 42 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Anavex Life Sciences Corporation (AVXL) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Anavex Life Sciences Corporation is 3.30%, while institutional ownership is 34.48%. The most recent insider transaction that took place on Jun 14 ’24, was worth 10,319. In this transaction Director of this company bought 2,835 shares at a rate of $3.64, taking the stock ownership to the 5,000 shares. Before that another transaction happened on May 15 ’24, when Company’s Director bought 5,000 for $4.52, making the entire transaction worth $22,600. This insider now owns 5,000 shares in total.
Anavex Life Sciences Corporation (AVXL) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -22.44% per share during the next fiscal year.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Trading Performance Indicators
Check out the current performance indicators for Anavex Life Sciences Corporation (AVXL). In the past quarter, the stock posted a quick ratio of 9.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach 1.32 in one year’s time.
Technical Analysis of Anavex Life Sciences Corporation (AVXL)
Analysing the last 5-days average volume posted by the [Anavex Life Sciences Corporation, AVXL], we can find that recorded value of 1.46 million was better than the volume posted last year of 1.34 million. As of the previous 9 days, the stock’s Stochastic %D was 18.50%. Additionally, its Average True Range was 0.69.
During the past 100 days, Anavex Life Sciences Corporation’s (AVXL) raw stochastic average was set at 5.78%, which indicates a significant decrease from 6.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.22% in the past 14 days, which was lower than the 91.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.80, while its 200-day Moving Average is $7.51. Now, the first resistance to watch is $8.39. This is followed by the second major resistance level at $9.17. The third major resistance level sits at $9.66. If the price goes on to break the first support level at $7.12, it is likely to go to the next support level at $6.63. Now, if the price goes above the second support level, the third support stands at $5.85.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Key Stats
There are currently 85,064K shares outstanding in the company with a market cap of 646.49 million. Presently, the company’s annual sales total 0 K according to its annual income of -43,000 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,110 K.
